The kinetics (8, 12, 17, 18) as well as the control mechanisms (2, 11, 12, 17, 18) 5 ,ug of tunicamycin per ml was added. Invertase activity was measured after incubation at 30°C for the times indicated. (B and C) Strain ATCC 42407 was grown in 2% glucose. At the beginning of exponential growth, the culture was divided into two portions; to one portion (dotted lines), 5 ,ug of tunicamycin per ml was added. After incubation at 30°C, the cells were harvested, washed with an equal volume of water, and extracted, and glucose-6-phosphate dehydrogenase (B) and glucosephosphate isomerase (C) activities were measured. (D) Strain ATCC 42407 was grown and treated as described above, and the total protein content (0) was measured. In experiments with leucine incorporation (O), 0.5 ,uCi of L-[U-14C]leucine per ml was added at the beginning of exponential growth, and the culture was divided into two portions. To one portion (dotted lines), 5 ,ug of tunicamycin per ml was added, and the radioactivity incorporated into the insoluble fraction in hot 5% trichloroacetic acid was measured.
(SUC2 gal2 mal CUP]), were grown aerobically at 30°C in a rich medium containing 1% (wt/vol) yeast extract, 2% (wt/vol) peptone, and glucose, maltose, or galactose as needed in each case. In experiments with radioactive-leucine incorporation, a medium containing 0.3% (wt/vol) yeast extract and 2% galactose was used. Cell growth was followed by measuring the optical density at 640 nm or by determining the dry weight. Total protein (9) and glucose (19) were determined as described previously. The activity of external invertase was determined as described previously (7) . Cell extracts prepared as described previously (6) were used to determine the activities of glucose-6-phosphate dehydrogenase (16) and glucosephosphate isomerase (10) . The activities of glucose, maltose, and galactose transport systems were determined as described previously (11) . The marker mannoprotein of the yeast cell wall was released from labeled cells and analyzed as described previously (15) .
The addition of tunicamycin to exponentially growing cells inhibited the biosynthesis of the two known components (2) of the glucose transport system (Fig. 1A) . A similar effect was observed on the biosynthesis of the galactose carrier (Fig. 1B) as well as the two components (3) of the maltose carrier (Fig. 1C) . Under the experimental conditions used, tunicamycin also inhibited the biosynthesis of invertase, (Fig. 2A) , a well-known glycoprotein, as well as the glycosylation of a marker mannoprotein of the yeast cell wall (15) . The 33-kilodalton (kDa) mannoprotein present in control cells (Fig. 3, lane a) was transformed into the 30.5-kDa deglycosylated form of the protein in cells treated with tunicamycin (Fig. 3, lane c) (15) . This result was confirmed by the fact that in vitro deglycosylation of the 33-kDa protein by endo-,3-N-acetylglucosaminidase H also gave rise to the 30.5-kDa protein (Fig. 3, lane b) . (The molecular sizes of 29 and 26 kDa, respectively, for the glycosylated and deglycosylated forms of this mannoprotein have been previously reported (15) . However, the actual values are those mentioned above [E. Herrero and R. Sentandreu, personal communication].)
However, the addition of tunicamycin to exponentially growing cells had no effect on the biosynthesis of proteins that do not contain carbohydrate, e.g., glucose-6-phosphate dehydrogenase (1) and glucosephosphate isomerase (14) . Indeed, the activities of both enzymes continued increasing even 2 h after antibiotic addition ( Fig. 2B and C) . Also, an increase in total protein content and radioactive-leucineincorporation into proteins was observed during this period (Fig. 2D) .
These results suggest that the glucose, maltose, and galactose carriers of S. cerevisiae are glycoproteins. 
